Buprenorphine X-Waiver Training WebinarDATE: Tuesday, July 21, 2020
TIME: 12:30-5:00 p.m. CST
LOCATION: Zoom Webinar (Link provided once registered)
PRESENTER: Mark Lim, MD
After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available.
Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine. This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their Buprenorphine Waver through the American Society of Addiction Medicine.
ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours. The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.
ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.